New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Ocugen, Inc. (OCGN) vs Q32 Bio Inc. (QTTB)
- Ocugen, Inc. OCGN 0.77 +5.48%
- Q32 Bio Inc. QTTB 8.34 −1.65%
Ocugen, Inc. and Q32 Bio Inc. are both Biotechnology companies. Ocugen, Inc. and Q32 Bio Inc. are of similar size ($253.8M and $248.6M). Ocugen, Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Ocugen, Inc. grew revenue faster over the last twelve months: −11.0% against −307.3%. Q32 Bio Inc. has the higher net margin (808.0% vs −1,367.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Q32 Bio Inc. leads on 10 and Ocugen, Inc. on 3.
Valuation
Profitability
| Metric | OCGN | QTTB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (1,444.47%) | 725.53% | 0.00% |
| Net margin | (1,367.61%) | 808.04% | 0.00% |
| Free cash flow margin | (1,337.16%) | 280.89% | 0.00% |
| Return on equity | 923.92% | 23.96% | (51.58%) |
| Return on assets | (78.91%) | 18.17% | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack